News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
CICON24, an unmissable event for anyone interested in advancing cancer immunotherapy – Cancer Research Institute
Photo from Cancer Research Institute/LinkedIn
May 28, 2024, 03:05

CICON24, an unmissable event for anyone interested in advancing cancer immunotherapy – Cancer Research Institute

Cancer Research Institute (CRI) shared on LinkedIn:

“Abstract submission closes on June 3 for CICON24, an unmissable event for anyone interested in advancing cancer immunotherapy. Submit an abstract today to be part of the conversation shaping the future of cancer treatment! All abstracts will be considered for short oral presentations.”

Source: Cancer Research Institute/LinkedIn

Abstract submission advancing cancer immunotherapy cancer Cancer Research Institute cancer treatment CICON24 CRI OncoDaily Oncology
Societies
Aug 17, 2024, 10:11
Download Cancer PathCHART 2025 Site-Morphology Standards for cancer surviellance - NCI Division of Cancer Control and Population Sciences
Positive
Aug 17, 2024, 09:13
Harpreet Singh: Exciting news in colorectal cancer treatment
Insight
Aug 17, 2024, 09:04
Ralph DeBerardinis: Metabolism in human clear cell renal cell carcinoma
Insight
Aug 17, 2024, 08:51
Haryana Dhillon: Adjusting to unexpected survivorship after exceptional response to cancer treatment
Insight
Aug 17, 2024, 08:50
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Blog
Aug 17, 2024, 08:43
Dario Trapani: Key actions to tackle current cancer trends toward United Nations SDGs and UHC
Insight
Aug 17, 2024, 08:24
Estela Rodriguez: Great first step to having more inclusion and representation of data included in ASCO guidelines
Blog
Aug 17, 2024, 08:20
Eric K. Singhi: Can’t-miss presentations during the Presidential Symposium of WCLC24
Societies
Aug 17, 2024, 08:18
Highlights from KCancer by the Jimmy Fund
Blog
Aug 17, 2024, 08:15
Mahadi Baig: U.S. FDA granted priority review of Johnson and Johnson Innovative Medicine's subcutaneous treatment for patients with EGFR-mutated NSCLC
Blog
Aug 17, 2024, 08:12
ESMO encourages delegates to opt for climate-friendly travelling
Insight
Aug 17, 2024, 08:07
Liang Cheng: An exciting time to study bladder cancer